First Time Loading...
A

Aceso Life Science Group Ltd
HKEX:474

Watchlist Manager
Aceso Life Science Group Ltd
HKEX:474
Watchlist
Price: 0.144 HKD -2.04%
Updated: May 21, 2024

Net Margin
Aceso Life Science Group Ltd

-159.1%
Current
-93%
Average
14.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-159.1%
=
Net Income
-420m
/
Revenue
264m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
HK
Aceso Life Science Group Ltd
HKEX:474
1.1B HKD
-159%
US
American Express Co
NYSE:AXP
174.2B USD
13%
US
Capital One Financial Corp
NYSE:COF
53.7B USD
13%
IN
Bajaj Finance Ltd
NSE:BAJFINANCE
4.2T INR
26%
US
Discover Financial Services
NYSE:DFS
31.3B USD
13%
US
Synchrony Financial
NYSE:SYF
17.7B USD
15%
IN
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
1.1T INR
18%
US
Santander Consumer USA Holdings Inc
NYSE:SC
12.7B USD
40%
US
Ally Financial Inc
NYSE:ALLY
12B USD
8%
BR
Creditaqui Financeira SA - Credito Financiamento e Investimento
BOVESPA:MERC3
56B BRL
-7%
IN
Shriram Finance Ltd
NSE:SHRIRAMFIN
891.9B INR
20%
A
Aceso Life Science Group Ltd
HKEX:474
Country HK
Market Cap 1.1B HKD
Net Margin
-159%
American Express Co
NYSE:AXP
Country US
Market Cap 174.2B USD
Net Margin
13%
Capital One Financial Corp
NYSE:COF
Country US
Market Cap 53.7B USD
Net Margin
13%
Bajaj Finance Ltd
NSE:BAJFINANCE
Country IN
Market Cap 4.2T INR
Net Margin
26%
Discover Financial Services
NYSE:DFS
Country US
Market Cap 31.3B USD
Net Margin
13%
Synchrony Financial
NYSE:SYF
Country US
Market Cap 17.7B USD
Net Margin
15%
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
Country IN
Market Cap 1.1T INR
Net Margin
18%
Santander Consumer USA Holdings Inc
NYSE:SC
Country US
Market Cap 12.7B USD
Net Margin
40%
Ally Financial Inc
NYSE:ALLY
Country US
Market Cap 12B USD
Net Margin
8%
Creditaqui Financeira SA - Credito Financiamento e Investimento
BOVESPA:MERC3
Country BR
Market Cap 56B BRL
Net Margin
-7%
Shriram Finance Ltd
NSE:SHRIRAMFIN
Country IN
Market Cap 891.9B INR
Net Margin
20%

Profitability Report

View the profitability report to see the full profitability analysis for Aceso Life Science Group Ltd.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-159.1%
=
Net Income
-420m
/
Revenue
264m
What is the Net Margin of Aceso Life Science Group Ltd?

Based on Aceso Life Science Group Ltd's most recent financial statements, the company has Net Margin of -159.1%.

ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.